Literature DB >> 11082143

Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative.

S Wassertheil-Smoller1, G Anderson, B M Psaty, H R Black, J Manson, N Wong, J Francis, R Grimm, T Kotchen, R Langer, N Lasser.   

Abstract

Little is known about the patterns of treatment and adequacy of blood pressure control in older women. The Women's Health Initiative, a 40-center national study of risk factors and prevention of heart disease, breast and colorectal cancer, and osteoporosis in postmenopausal women, provides a unique opportunity to examine these issues in the largest, multiethnic, best-characterized such cohort. Baseline data from the initial 98 705 women, aged 50 to 79 years, enrolled were analyzed to relate prevalence, treatment, and control of hypertension to demographic, clinical, and risk-factor covariates, and logistic regression analyses were performed to estimate odds ratios after adjusting for multiple potential confounders. Overall, 37.8% of the women had hypertension, which is defined as systolic blood pressure >/=140 mm Hg and/or diastolic blood pressure >/=90 mm Hg or being on medication for high blood pressure; 64.3% were treated with drugs, and blood pressure was controlled in only 36.1% of the hypertensive women, with lower rates of control in the oldest group. After adjustment for multiple covariates, current hormone users had higher prevalence than did nonusers (odds ratio 1.25). Hypertensive women had more comorbid conditions than did nonhypertensive women, and women with comorbidities were more likely to be treated pharmacologically. Diuretics were used by 44.3% of hypertensives either as monotherapy or in combination with other drug classes. As monotherapy, calcium channel blockers were used in 16%, angiotensin-converting enzyme inhibitors in 14%, beta-blockers in 9%, and diuretics in 14% of the hypertensive women. Diuretics as monotherapy were associated with better blood pressure control than any of the other drug classes as monotherapy. In conclusion, hypertension in older women is not being treated aggressively enough because a large proportion, especially those most at risk for stroke and heart disease by virtue of age, does not have sufficient blood pressure control.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082143     DOI: 10.1161/01.hyp.36.5.780

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  71 in total

1.  Association of Psychosocial Symptoms, Blood Pressure, and Menopausal Status in African-American Women.

Authors:  Carolyn H Still; Sadia Tahir; Hossein N Yarandi; Mona Hassan; Faye A Gary
Journal:  West J Nurs Res       Date:  2020-06-26       Impact factor: 1.967

Review 2.  Recent clinical trial highlights in hypertension.

Authors:  F C Luft
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

3.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

4.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

5.  Race, ethnicity, and self-reported hypertension: analysis of data from the National Health Interview Survey, 1997-2005.

Authors:  Luisa N Borrell
Journal:  Am J Public Health       Date:  2008-12-04       Impact factor: 9.308

6.  A window of opportunity: improving cardiovascular health in women.

Authors:  T Jaarsma
Journal:  Neth Heart J       Date:  2009-02       Impact factor: 2.380

Review 7.  Drospirenone, a new progestogen, for postmenopausal women with hypertension.

Authors:  Madhavi Mallareddy; Vladimir Hanes; William B White
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Hypertension in women: latest findings and clinical implications.

Authors:  Helga Gudmundsdottir; Aud Høieggen; Aud Stenehjem; Bård Waldum; Ingrid Os
Journal:  Ther Adv Chronic Dis       Date:  2012-05       Impact factor: 5.091

9.  Roles played by 20-HETE, angiotensin II and endothelin in mediating the hypertension in aging female spontaneously hypertensive rats.

Authors:  Roberta Lima; Licy L Yanes; Deborah D Davis; Jane F Reckelhoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-12-05       Impact factor: 3.619

Review 10.  Neural and nonneural mechanisms for sex differences in elderly hypertension: can exercise training help?

Authors:  Qi Fu; Wanpen Vongpatanasin; Benjamin D Levine
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.